• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,3,5-三芳基-2-吡唑啉衍生物作为脲酶和α-葡萄糖苷酶的强效双重抑制剂的合成、评价及其细胞毒性、分子模拟和类药性质研究

Synthesis and Evaluation of 1,3,5-Triaryl-2-Pyrazoline Derivatives as Potent Dual Inhibitors of Urease and α-Glucosidase Together with Their Cytotoxic, Molecular Modeling and Drug-Likeness Studies.

作者信息

Mehmood Rabia, Sadiq Amina, Alsantali Reem I, Mughal Ehsan Ullah, Alsharif Meshari A, Naeem Nafeesa, Javid Asif, Al-Rooqi Munirah M, Chaudhry Gul-E-Saba, Ahmed Saleh A

机构信息

Department of Chemistry, Govt. College Women University, Sialkot 51300, Pakistan.

Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.

出版信息

ACS Omega. 2022 Jan 20;7(4):3775-3795. doi: 10.1021/acsomega.1c06694. eCollection 2022 Feb 1.

DOI:10.1021/acsomega.1c06694
PMID:35128286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8811919/
Abstract

In the present work, a concise library of 1,3,5-triaryl-2-pyrazolines () was designed and synthesized by employing a multistep strategy, and the newly synthesized compounds were screened for their urease and α-glucosidase inhibitory activities. The compounds () were characterized using a combination of several spectroscopic techniques including FT-IR, H NMR, C NMR, and EI-MS. All the synthesized compounds, except compound were potent against urease as compared to the standard inhibitor thiourea (IC = 21.37 ± 0.26 μM). These analogs disclosed varying degrees of urease inhibitory activities ranging from 9.13 ± 0.25 to 18.42 ± 0.42 μM. Compounds , and having IC values of 9.36 ± 0.27, 9.13 ± 0.25, 9.18 ± 0.35, and 9.35 ± 0.35 μM, respectively, showed excellent inhibitory activity as compared to standard thiourea (IC = 21.37 ± 0.26 μM). A kinetic study of compound revealed that compound inhibited urease in a competitive mode. Among the synthesized pyrazolines, the compounds , and exhibited excellent α-glucosidase inhibitory activity with the lowest IC values of 212.52 ± 1.31, 237.26 ± 1.28, 138.35 ± 1.32, and 114.57 ± 1.35 μM, respectively, as compared to the standard acarbose (IC = 375.82 ± 1.76 μM). The compounds ( showed α-glucosidase IC values in the range of 114.57 ± 1.35 to 462.94 ± 1.23 μM. Structure-activity relationship revealed that the size and electron-donating or -withdrawing effects of substituents influenced the activities, which led to the urease and α-glucosidase inhibiting properties. Compound was a dual potent inhibitor against urease and α-glucosidase due to the presence of 2-CF electron-withdrawing functionality on the phenyl ring. To the best of our knowledge, these synthetic compounds were found to be the most potent dual inhibitors of urease and α-glucosidase with minimum IC values. The cytotoxicity of the compounds () was also investigated against human cell lines MCF-7 and HeLa. Compound showed moderate cytotoxic activity against MCF-7 and HeLa cell lines. Moreover, in silico studies on most active compounds were also performed to understand the binding interaction of most active compounds with active sites of urease and α-glucosidase enzymes. Some compounds exhibited drug-like characteristics due to their lower cytotoxic and good ADME profiles.

摘要

在本研究中,采用多步策略设计并合成了一个简洁的1,3,5 - 三芳基 - 2 - 吡唑啉类化合物库,并对新合成的化合物进行了脲酶和α - 葡萄糖苷酶抑制活性筛选。使用包括傅里叶变换红外光谱(FT - IR)、氢核磁共振(H NMR)、碳核磁共振(C NMR)和电子轰击质谱(EI - MS)在内的多种光谱技术对化合物进行了表征。与标准抑制剂硫脲(IC = 21.37 ± 0.26 μM)相比,除化合物 外,所有合成化合物对脲酶均具有强效抑制作用。这些类似物展现出不同程度的脲酶抑制活性,范围为9.13 ± 0.25至18.42 ± 0.42 μM。化合物 、 和 的IC值分别为9.36 ± 0.27、9.13 ± 0.25、9.18 ± 0.35和9.35 ± 0.35 μM,与标准硫脲(IC = 21.37 ± 0.26 μM)相比,显示出优异的抑制活性。对化合物 的动力学研究表明,化合物 以竞争模式抑制脲酶。在合成的吡唑啉类化合物中,化合物 、 和 表现出优异的α - 葡萄糖苷酶抑制活性,与标准阿卡波糖(IC = 375.82 ± 1.76 μM)相比,最低IC值分别为212.52 ± 1.31、237.26 ± 1.28、138.35 ± 1.32和114.57 ± 1.35 μM。化合物 显示出α - 葡萄糖苷酶IC值在114.57 ± 1.35至462.94 ± 1.23 μM范围内。构效关系表明,取代基的大小和供电子或吸电子效应影响了活性,进而导致了脲酶和α - 葡萄糖苷酶的抑制特性。由于苯环上存在2 - CF吸电子官能团,化合物 是一种对脲酶和α - 葡萄糖苷酶均有效的双重抑制剂。据我们所知,这些合成化合物被发现是脲酶和α - 葡萄糖苷酶最有效的双重抑制剂,IC值最低。还研究了化合物 对人细胞系MCF - 7和HeLa的细胞毒性。化合物 对MCF - 7和HeLa细胞系表现出中等细胞毒性活性。此外,还对最具活性的化合物进行了计算机模拟研究,以了解最具活性的化合物与脲酶和α - 葡萄糖苷酶活性位点的结合相互作用。一些化合物由于其较低的细胞毒性和良好的药物代谢动力学性质而表现出类药物特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/04a07f2c25a9/ao1c06694_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/218281afff06/ao1c06694_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/0625d7928245/ao1c06694_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/f455ea8a6885/ao1c06694_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/5647a878b2c3/ao1c06694_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/998d21405fd4/ao1c06694_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/04d7b381435d/ao1c06694_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/0066ff968007/ao1c06694_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/8fde4a75cf15/ao1c06694_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/c249896d5502/ao1c06694_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/3b0eaab41346/ao1c06694_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/59d6c1205c14/ao1c06694_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/71a7361ee050/ao1c06694_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/db785d4c5b93/ao1c06694_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/2e91d9d08ed1/ao1c06694_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/18419ac434ed/ao1c06694_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/04a07f2c25a9/ao1c06694_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/218281afff06/ao1c06694_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/0625d7928245/ao1c06694_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/f455ea8a6885/ao1c06694_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/5647a878b2c3/ao1c06694_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/998d21405fd4/ao1c06694_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/04d7b381435d/ao1c06694_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/0066ff968007/ao1c06694_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/8fde4a75cf15/ao1c06694_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/c249896d5502/ao1c06694_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/3b0eaab41346/ao1c06694_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/59d6c1205c14/ao1c06694_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/71a7361ee050/ao1c06694_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/db785d4c5b93/ao1c06694_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/2e91d9d08ed1/ao1c06694_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/18419ac434ed/ao1c06694_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8802/8811919/04a07f2c25a9/ao1c06694_0016.jpg

相似文献

1
Synthesis and Evaluation of 1,3,5-Triaryl-2-Pyrazoline Derivatives as Potent Dual Inhibitors of Urease and α-Glucosidase Together with Their Cytotoxic, Molecular Modeling and Drug-Likeness Studies.1,3,5-三芳基-2-吡唑啉衍生物作为脲酶和α-葡萄糖苷酶的强效双重抑制剂的合成、评价及其细胞毒性、分子模拟和类药性质研究
ACS Omega. 2022 Jan 20;7(4):3775-3795. doi: 10.1021/acsomega.1c06694. eCollection 2022 Feb 1.
2
The Synthesis, In Vitro Bio-Evaluation, and In Silico Molecular Docking Studies of Pyrazoline-Thiazole Hybrid Analogues as Promising Anti-α-Glucosidase and Anti-Urease Agents.吡唑啉-噻唑杂化类似物作为有前景的抗α-葡萄糖苷酶和抗脲酶剂的合成、体外生物评价及计算机辅助分子对接研究
Pharmaceuticals (Basel). 2023 Nov 25;16(12):1650. doi: 10.3390/ph16121650.
3
Novel pyrazoline linked acyl thiourea pharmacophores as antimicrobial, urease, amylase and α-glucosidase inhibitors: design, synthesis, SAR and molecular docking studies.新型吡唑啉连接的酰基硫脲药效团作为抗菌、脲酶、淀粉酶和α-葡萄糖苷酶抑制剂:设计、合成、构效关系及分子对接研究
RSC Adv. 2024 Jan 2;14(2):1018-1033. doi: 10.1039/d3ra06812a.
4
Synthesis of amantadine clubbed -aryl amino thiazoles as potent urease, α-amylase & α-glucosidase inhibitors, kinetic and molecular docking studies.金刚烷胺连接芳基氨基噻唑类化合物作为强效脲酶、α-淀粉酶和α-葡萄糖苷酶抑制剂的合成、动力学及分子对接研究
RSC Adv. 2023 Aug 22;13(36):24988-25001. doi: 10.1039/d3ra05330j. eCollection 2023 Aug 21.
5
Three New Acrylic Acid Derivatives from as Potential Inhibitors of Urease from Jack Bean and -Glucosidase from .三种新型丙烯酸衍生物来源于 ,有望成为刀豆脲酶和 的抑制剂。
Molecules. 2022 Aug 6;27(15):5004. doi: 10.3390/molecules27155004.
6
Synthesis, In Vitro Anti-Microbial Analysis and Molecular Docking Study of Aliphatic Hydrazide-Based Benzene Sulphonamide Derivatives as Potent Inhibitors of α-Glucosidase and Urease.基于脂肪族酰肼的苯磺酰胺衍生物的合成、体外抗微生物分析和分子对接研究作为α-葡萄糖苷酶和脲酶的有效抑制剂。
Molecules. 2022 Oct 21;27(20):7129. doi: 10.3390/molecules27207129.
7
5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α-glucosidase and urease enzymes.5-溴-2-芳基苯并咪唑衍生物作为α-葡萄糖苷酶和脲酶的非细胞毒性潜在双重抑制剂
Bioorg Chem. 2017 Jun;72:21-31. doi: 10.1016/j.bioorg.2017.03.007. Epub 2017 Mar 20.
8
Design, Synthesis, and Structural Characterization of Thioflavones and Thioflavonols as Potential Tyrosinase Inhibitors: In Vitro and In Silico Studies.作为潜在酪氨酸酶抑制剂的硫代黄酮和硫代黄酮醇的设计、合成及结构表征:体外和计算机模拟研究
ACS Omega. 2022 May 10;7(20):17444-17461. doi: 10.1021/acsomega.2c01841. eCollection 2022 May 24.
9
Synthesis of new arylhydrazide bearing Schiff bases/thiazolidinone: α-Amylase, urease activities and their molecular docking studies.合成含席夫碱/噻唑烷酮的新型芳基酰肼:α-淀粉酶、脲酶活性及其分子对接研究。
Bioorg Chem. 2019 Oct;91:103112. doi: 10.1016/j.bioorg.2019.103112. Epub 2019 Jul 9.
10
Synthesis, Biological Evaluation and in Silico Studies of New Pyrazoline Derivatives Bearing Benzo[d]thiazol-2(3H)-one Moiety as Potential Urease Inhibitors.新型含苯并[d]噻唑-2(3H)-酮部分的吡唑啉衍生物的合成、生物评价及计算机研究作为潜在的脲酶抑制剂。
Chem Biodivers. 2022 Mar;19(3):e202100826. doi: 10.1002/cbdv.202100826. Epub 2022 Feb 9.

引用本文的文献

1
Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives.基于吡唑啉的抗分枝杆菌药物的设计与开发进展:最新情况与未来展望
RSC Adv. 2025 Sep 1;15(38):31360-31401. doi: 10.1039/d5ra03759j. eCollection 2025 Aug 29.
2
Comprehensive assessment of 3-benzyloxyflavones as β-glucosidase inhibitors: , , kinetic, SAR and computational studies.3-苄氧基黄酮作为β-葡萄糖苷酶抑制剂的综合评估: , ,动力学、构效关系及计算研究。
RSC Adv. 2025 Apr 4;15(14):10484-10500. doi: 10.1039/d4ra08558b.
3
Cytotoxic effect and apoptotic induction of tricyclohexyltin p-methoxycinnamate on HT-29 colorectal cancer cells: Implications for anticancer therapeutics.

本文引用的文献

1
Identification of novel bacterial urease inhibitors through molecular shape and structure based virtual screening approaches.通过基于分子形状和结构的虚拟筛选方法鉴定新型细菌脲酶抑制剂。
RSC Adv. 2020 Apr 22;10(27):16061-16070. doi: 10.1039/d0ra02363a. eCollection 2020 Apr 21.
2
Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.吲哚衍生物的合成及其作为糖尿病 II 抑制剂的研究和α-葡萄糖苷酶和α-淀粉酶的酶动力学研究及其计算机模拟研究。
Int J Biol Macromol. 2021 Nov 1;190:301-318. doi: 10.1016/j.ijbiomac.2021.08.207. Epub 2021 Sep 2.
3
对甲氧基肉桂酸三环己基锡对HT-29结肠癌细胞的细胞毒性作用及凋亡诱导:对抗癌治疗的意义。
J Adv Pharm Technol Res. 2025 Jan-Mar;16(1):1-5. doi: 10.4103/JAPTR.JAPTR_427_23. Epub 2025 Feb 14.
4
3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentials.3,5-二取代吡唑啉作为一种有前景的抗癌药物核心结构:作用机制与治疗潜力
Future Med Chem. 2025 Mar;17(6):725-745. doi: 10.1080/17568919.2025.2476393. Epub 2025 Mar 13.
5
Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis.探索吡唑啉作为新型冠状病毒NSP3-巨结构域潜在抑制剂:合成与计算机模拟分析
Sci Rep. 2025 Jan 4;15(1):767. doi: 10.1038/s41598-024-81711-5.
6
Synthesis, Urease Inhibition, Molecular Docking, and Optical Analysis of a Symmetrical Schiff Base and Its Selected Metal Complexes.对称希夫碱及其部分金属配合物的合成、脲酶抑制、分子对接和光学分析。
Molecules. 2024 Oct 16;29(20):4899. doi: 10.3390/molecules29204899.
7
The Synthesis, In Vitro Bio-Evaluation, and In Silico Molecular Docking Studies of Pyrazoline-Thiazole Hybrid Analogues as Promising Anti-α-Glucosidase and Anti-Urease Agents.吡唑啉-噻唑杂化类似物作为有前景的抗α-葡萄糖苷酶和抗脲酶剂的合成、体外生物评价及计算机辅助分子对接研究
Pharmaceuticals (Basel). 2023 Nov 25;16(12):1650. doi: 10.3390/ph16121650.
8
Exploring the potential of propanamide-sulfonamide based drug conjugates as dual inhibitors of urease and cyclooxygenase-2: biological and their studies.探索基于丙酰胺-磺酰胺的药物偶联物作为脲酶和环氧化酶-2双重抑制剂的潜力:生物学及其研究
Front Chem. 2023 Aug 3;11:1206380. doi: 10.3389/fchem.2023.1206380. eCollection 2023.
9
Finding a Novel Chalcone-Cinnamic Acid Chimeric Compound with Antiproliferative Activity against MCF-7 Cell Line Using a Free-Wilson Type Approach.采用自由 Wilson 型方法寻找具有抗 MCF-7 细胞系增殖活性的新型查尔酮-肉桂酸嵌合化合物。
Molecules. 2023 Jul 18;28(14):5486. doi: 10.3390/molecules28145486.
10
Current status of -, -, -heterocycles as potential alkaline phosphatase inhibitors: a medicinal chemistry overview.作为潜在碱性磷酸酶抑制剂的-,-,-杂环的现状:药物化学综述。
RSC Adv. 2023 Jun 1;13(24):16413-16452. doi: 10.1039/d3ra01888a. eCollection 2023 May 30.
Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
新型四氢苯并[b]噻吩-2-基)脲衍生物作为新型α-葡萄糖苷酶抑制剂的研究:合成、动力学研究、分子对接及体内降血糖活性评价。
Bioorg Chem. 2021 Oct;115:105236. doi: 10.1016/j.bioorg.2021.105236. Epub 2021 Aug 8.
4
Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and in silico studies.鉴定苯甲酰胺嗪烷-1,3,4-恶二唑酰胺类化合物为脂氧合酶抑制剂:表达分析与计算机模拟研究。
Bioorg Chem. 2021 Oct;115:105243. doi: 10.1016/j.bioorg.2021.105243. Epub 2021 Aug 4.
5
Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study.新型喹唑啉酮-吡唑衍生物的设计与合成及其作为潜在α-葡萄糖苷酶抑制剂的活性评价:构效关系、分子模拟及动力学研究。
Bioorg Chem. 2021 Sep;114:105127. doi: 10.1016/j.bioorg.2021.105127. Epub 2021 Jun 29.
6
Synthesis of novel 5-(2,5-bis(2,2,2-trifluoroethoxy)phenyl)-1,3,4-oxadiazole-2-thiol derivatives as potential glucosidase inhibitors.合成新型 5-(2,5-双(2,2,2-三氟乙氧基)苯基)-1,3,4-恶二唑-2-硫醇衍生物作为潜在的葡萄糖苷酶抑制剂。
Bioorg Chem. 2021 Sep;114:105046. doi: 10.1016/j.bioorg.2021.105046. Epub 2021 May 31.
7
Discovery of Novel Dihydropyrimidine and hydroxamic acid hybrids as potent Helicobacter pylori Urease inhibitors.发现新型嘧啶并[D]嘧啶和偕氨肟酸杂合体作为有效的幽门螺杆菌脲酶抑制剂。
Bioorg Chem. 2021 Sep;114:105010. doi: 10.1016/j.bioorg.2021.105010. Epub 2021 May 28.
8
Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors.具有磺胺二甲嘧啶骨架的新型抑制剂:多靶点胆碱酯酶和α-葡萄糖苷酶抑制剂的合成及生物学研究
J Biomol Struct Dyn. 2022;40(19):8752-8764. doi: 10.1080/07391102.2021.1916599. Epub 2021 May 5.
9
Structure-based designing and synthesis of 2-phenylchromone derivatives as potent tyrosinase inhibitors: In vitro and in silico studies.基于结构的 2-苯基色酮衍生物的设计与合成及其作为酪氨酸酶抑制剂的活性:体外和计算研究。
Bioorg Med Chem. 2021 Apr 1;35:116057. doi: 10.1016/j.bmc.2021.116057. Epub 2021 Feb 9.
10
Therapeutic potential of N-substituted thiosemicarbazones as new urease inhibitors: Biochemical and in silico approach.N-取代硫代缩氨基脲作为新型脲酶抑制剂的治疗潜力:生化和计算方法。
Bioorg Chem. 2021 Apr;109:104691. doi: 10.1016/j.bioorg.2021.104691. Epub 2021 Feb 2.